eggXYt Patents

Patent portfolio assigned to eggXYt (verified via public assignee records). Jerusalem, Israel; CRISPR-based in-ovo / pre-incubation chick sexing (luminescent biomarker on male chromosome). Competitors are in-ovo sexing players. No named paying customers disclosed (pre-commercial SaaS 'sexing-as-a-service' model). Patents confirmed: applicant 'Eggxyt Ltd' on WO2018216022A1 (plus later PCT/IL2020/050242); exact count not enumerated.